Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase EARLY_PHASE1 1Phase 2 1

Status

Terminated 2Completed 2

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4Observational 3

Sponsor

Cancer Type

Head & Neck 2Tumor-Agnostic 1Genitourinary 1

Conditions

Thyroid Neoplasms 2Thyroid Diseases 2Prostatic Neoplasms 1Neoplasms 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Sodium × Clear all
NCT01031420 2019-09-17

Dose Dense MVAC for Muscle Invasive Bladder Cancer

Fox Chase Cancer Center

Phase 2 Completed
54 enrolled 7 charts
Tumor-Agnostic

Neoplasms

NCT02190279 2019-04-23

18F-DCFBC PET/CT in Prostate Cancer

National Institutes of Health Clinical Center (CC)

Phase EARLY_PHASE1 Completed
116 enrolled 23 charts
Genitourinary

Prostatic Neoplasms

NCT00926978 2018-11-01

Comparison of Iodine-124 (I-124) and Iodine-131 (I-131) Radiopharmacokinetics in Patients Prepared With Recombinant Human TSH Injection (rhTSH)

Medstar Health Research Institute

Phase NA Terminated
21 enrolled
Head & Neck

Thyroid Diseases, Thyroid Neoplasms

NCT02947399 2018-11-01

Comparison of I-124 and I-131 Radiopharmacokinetics in DTC Patients With Thyroid Hormone Withdrawal

Medstar Health Research Institute

Phase NA Terminated
16 enrolled
Head & Neck

Thyroid Diseases, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡